cam a22 4 4500 390168432 CHVBK 20200625103101.0 161201s2016 xxuab b 001 0deng| 2015037355 978-0-8135-7439-4 hbk. 0-8135-7439-0 hbk. 978-0-8135-7440-0 ePub 978-0-8135-7441-7 Web PDF 9780813574394 (IDSLU)001275092 (IDSBB)006651038 (NEBIS)010660000 (VAUD)991021130799002852 (OCoLC)927618771 (EXLNZ-41BCULAUSA_NETWORK)991023453137702851 DLC ger SzZuIDS LU rda eng RA644.P9 M39 2016 WC 556 .M462s 2016 2017 C-382 WC 556 614.5/490973 23 Mawdsley Stephen E. Verfasser aut Selling science polio and the promise of gamma globulin Stephen E. Mawdsley New Brunswick Rutgers University Press [2016] xiii, 210 Seiten Illustrationen 24 cm Critical issues in health and medicine Publié aussi sous forme numérique avec l'e-ISBN 9780813574400 au format ePub. Publié aussi sous forme numérique avec l'e-ISBN 9780813574417 au format Web PDF. Includes bibliographical references and index Forging momentum -- Building consent for a clinical trial -- Marketing and mobilization -- Selling science -- Operation marbles and lollipops -- The national experiment "In Selling Science : Polio and the Promise of Gamma Globulin, medical historian Stephen E. Mawdsley examines the untold story of the first effort to control polio prior to the development of the Salk vaccine. In the early 1950s, Dr. William McD. Hammon and the National Foundation for Infantile Paralysis launched a pioneering medical experiment on a previously untried scale. Conducted on over 55,000 healthy children in Texas, Utah, Iowa, and Nebraska, this landmark study attempted to assess the safety and effectiveness of a blood component, 'gamma globulin' (which is derived by a process known as 'fractionation') to prevent paralytic polio. Although the study was condemned by many prominent health professionals, harbored potential risks, and returned dubious results, it was perceived as a triumph and used to justify a national immunization program from 1953 to 1954"-- Hammon, William McD William McDowell 1904-1989 Hammon, William McD William McDowell 1904-1989 National Foundation for Infantile Paralysis National Foundation for Infantile Paralysis History Geschichte 1951-1954 gnd Child (DNLM)D002648 Clinical Trials as Topic history (DNLM)D002986Q000266 gamma-Globulins therapeutic use (DNLM)D005719Q000627 History, 20th Century (DNLM)D049673 Organizations, Nonprofit history (DNLM)D009939Q000266 Physicians history (DNLM)D010820Q000266 Poliomyelitis prevention & control (DNLM)D011051Q000517 Therapeutic Human Experimentation (DNLM)D036302 Vaccines therapeutic use (DNLM)D014612Q000627 Immunglobuline (DE-588)4026626-6 gnd Impfung (DE-588)4026656-4 gnd Kinderlähmung (DE-588)4163840-2 gnd Klinisches Experiment (DE-588)4164223-5 gnd Poliomyelitis United States Prevention History 20th century Gamma globulins Research United States History 20th century Children Diseases United States Prevention History 20th century Clinical trials United States History 20th century Science Social aspects History 20th century Science Economic aspects History 20th century Poliomyélite Prévention États-Unis 20e siècle ram Gammaglobulines Thérapeutique États-Unis 20e siècle ram Enfants Maladies Prévention États-Unis 20e siècle ram United States (DNLM)D014481 u XB 5200 idslu LR BK020000 XK020000 XK020000 Metadata rights reserved vaud UMHIZ-201607 nebis EN 011 IDS LU s1me rnv s2ht rnv VAUD iuhm iuhm HMA 26062 35p 810820001 NEBIS UMBC UMBC ULCAR WZ 70.A-143 IDSLU LUUHL LUUHL UHFRE XB 5200 2016 IDSBB B583 B583 MAG IMG WC 555 M462 NELB5831611 IDSLU 100 1- Mawdsley Stephen E. Verfasser aut IDSLU 490 0- Critical issues in health and medicine IDSBB 100 1- Mawdsley Stephen E. Verfasser aut IDSBB 490 0- Critical issues in health and medicine NEBIS 100 1- Mawdsley Stephen E. Verfasser aut NEBIS 490 0- Critical issues in health and medicine VAUD 100 1- Mawdsley Stephen E. aut VAUD 490 0- Critical issues in health and medicine IDSLU ILU50 ILU01 LUZHB https://www.ub.unibas.ch/tox/IDSLUZ/001275092/PDF pdf VIEW Inhaltsverzeichnis SWISSBIB 390168432